3-N-Butylphthalide
Butylphthalide may increase the anticoagulant activities of Ticagrelor.
Abciximab
Ticagrelor may increase the anticoagulant activities of Abciximab.
Aceclofenac
The metabolism of Aceclofenac can be decreased when combined with Ticagrelor.
Advertisement
Acenocoumarol
The metabolism of Acenocoumarol can be decreased when combined with Ticagrelor.
Acetaminophen
The metabolism of Acetaminophen can be decreased when combined with Ticagrelor.
Acetyl salicylate
Acetylsalicylic acid may increase the antiplatelet activities of Ticagrelor.
Advertisement
Acetyl Sulfisoxazole
The metabolism of Ticagrelor can be decreased when combined with Acetyl sulfisoxazole.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Ticagrelor.
Alosetron
The metabolism of Alosetron can be decreased when combined with Ticagrelor.
Advertisement
Aloxiprin
The risk or severity of adverse effects can be increased when Aloxiprin is combined with Ticagrelor.
alpha Tocopherol
Vitamin E may increase the antiplatelet activities of Ticagrelor.
Alprazolam
The metabolism of Alprazolam can be decreased when combined with Ticagrelor.
Alprostadil
Alprostadil may increase the anticoagulant activities of Ticagrelor.
Alteplase
Ticagrelor may increase the anticoagulant activities of Alteplase.
Aminopyrine
The metabolism of Aminophenazone can be decreased when combined with Ticagrelor.
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Aminosalicylic Acid is combined with Ticagrelor.
Amiodarone
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Amiodarone resulting in a loss in efficacy.
Amitriptyline
The metabolism of Amitriptyline can be decreased when combined with Ticagrelor.
Amprenavir
The metabolism of Amprenavir can be decreased when combined with Ticagrelor.
Anagrelide
Anagrelide may increase the anticoagulant activities of Ticagrelor.
Ancrod
Ticagrelor may increase the anticoagulant activities of Ancrod.
Anistreplase
Ticagrelor may increase the anticoagulant activities of Anistreplase.
Antipyrine
The metabolism of Antipyrine can be decreased when combined with Ticagrelor.
Antithrombin III
Ticagrelor may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Ticagrelor may increase the anticoagulant activities of Antithrombin III human.
Apalutamide
The serum concentration of Ticagrelor can be decreased when it is combined with Apalutamide.
Apixaban
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Apixaban.
Aprepitant
The serum concentration of Ticagrelor can be increased when it is combined with Aprepitant.
Aprotinin
The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Aprotinin.
Arachidonic Acid
The metabolism of Arachidonic Acid can be decreased when combined with Ticagrelor.
Ardeparin
Ticagrelor may increase the anticoagulant activities of Ardeparin.
Arformoterol
The metabolism of Arformoterol can be decreased when combined with Ticagrelor.
Argatroban
Ticagrelor may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Ticagrelor may increase the anticoagulant activities of Argatroban.
Artemether
The metabolism of Artemether can be decreased when combined with Ticagrelor.
Aspirin
Acetylsalicylic acid may increase the antiplatelet activities of Ticagrelor.
Astaxanthin
Ticagrelor may increase the anticoagulant activities of Astaxanthin.
Asunaprevir
The serum concentration of Asunaprevir can be increased when it is combined with Ticagrelor.
Atazanavir
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Atazanavir resulting in a loss in efficacy.
Atomoxetine
The metabolism of Ticagrelor can be decreased when combined with Atomoxetine.
Atorvastatin
The serum concentration of Atorvastatin can be increased when it is combined with Ticagrelor.
Avatrombopag
The metabolism of Avatrombopag can be decreased when combined with Ticagrelor.
Azelastine
The metabolism of Azelastine can be decreased when combined with Ticagrelor.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Ticagrelor.
Becaplermin
Ticagrelor may increase the anticoagulant activities of Becaplermin.
Bemiparin
Ticagrelor may increase the anticoagulant activities of Bemiparin.
Bexarotene
The metabolism of Bexarotene can be decreased when combined with Ticagrelor.
Bioallethrin
The metabolism of Bioallethrin can be decreased when combined with Ticagrelor.
Bivalirudin
Ticagrelor may increase the anticoagulant activities of Bivalirudin.
Boceprevir
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Boceprevir resulting in a loss in efficacy.
Bortezomib
The metabolism of Ticagrelor can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Bosentan can be increased when it is combined with Ticagrelor.
Bosentan Anhydrous
The serum concentration of Bosentan can be increased when it is combined with Ticagrelor.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Ticagrelor.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Ticagrelor.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Ticagrelor.
Brigatinib
The serum concentration of Ticagrelor can be decreased when it is combined with Brigatinib.
Brivaracetam
The metabolism of Brivaracetam can be decreased when combined with Ticagrelor.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Ticagrelor.
Brompheniramine
The metabolism of Brompheniramine can be decreased when combined with Ticagrelor.
Buprenorphine
The metabolism of Buprenorphine can be decreased when combined with Ticagrelor.
Bupropion
The metabolism of Bupropion can be decreased when combined with Ticagrelor.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Ticagrelor.
Cabozantinib
The metabolism of Cabozantinib can be decreased when combined with Ticagrelor.
Caffeine
The metabolism of Caffeine can be decreased when combined with Ticagrelor.
Candesartan
The metabolism of Candesartan can be decreased when combined with Ticagrelor.
Candesartan Cilexetil
The metabolism of Candesartan cilexetil can be decreased when combined with Ticagrelor.
Cangrelor
Cangrelor may increase the anticoagulant activities of Ticagrelor.
Cannabidiol
The metabolism of Cannabidiol can be decreased when combined with Ticagrelor.
Cannavis sativa susp. indica top extract
The metabolism of Medical Cannabis can be decreased when combined with Ticagrelor.
Carbamazepine
The serum concentration of Ticagrelor can be decreased when it is combined with Carbamazepine.
Carbinoxamine
The metabolism of Carbinoxamine can be decreased when combined with Ticagrelor.
Carvedilol
The serum concentration of Carvedilol can be increased when it is combined with Ticagrelor.
Celecoxib
The metabolism of Celecoxib can be decreased when combined with Ticagrelor.
Ceritinib
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Ceritinib resulting in a loss in efficacy.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Ticagrelor.
Certoparin
Ticagrelor may increase the anticoagulant activities of Certoparin.
Chlorpropamide
The metabolism of Chlorpropamide can be decreased when combined with Ticagrelor.
Cilostazol
Cilostazol may increase the anticoagulant activities of Ticagrelor.
Cinnarizine
The metabolism of Cinnarizine can be decreased when combined with Ticagrelor.
Cisapride
The metabolism of Cisapride can be decreased when combined with Ticagrelor.
Citric Acid
Ticagrelor may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Ticagrelor may increase the anticoagulant activities of Citric Acid.
Clarithromycin
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Clarithromycin resulting in a loss in efficacy.
Clemastine
The metabolism of Ticagrelor can be decreased when combined with Clemastine.
Clopidogrel
The metabolism of Clopidogrel can be decreased when combined with Ticagrelor.
Clotrimazole
The metabolism of Ticagrelor can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Clozapine can be decreased when combined with Ticagrelor.
Cobicistat
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Cobicistat resulting in a loss in efficacy.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Ticagrelor.
COLLAGENASE
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Collagenase clostridium histolyticum.
collagenase Clostridium histolyticum
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Collagenase clostridium histolyticum.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Ticagrelor.
Crizotinib
The metabolism of Ticagrelor can be decreased when combined with Crizotinib.
Curcumin
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Curcumin resulting in a loss in efficacy.
Cyclophosphamide
The metabolism of Cyclophosphamide can be decreased when combined with Ticagrelor.
Cyclophosphamide Anhydrous
The metabolism of Cyclophosphamide can be decreased when combined with Ticagrelor.
Cyclosporine
The serum concentration of Ticagrelor can be increased when it is combined with Cyclosporine.
Dabigatran Etexilate
Ticagrelor may increase the anticoagulant activities of Dabigatran etexilate.
Dabrafenib
The serum concentration of Ticagrelor can be decreased when it is combined with Dabrafenib.
Dalteparin
Ticagrelor may increase the anticoagulant activities of Dalteparin.
Danaparoid
Ticagrelor may increase the anticoagulant activities of Danaparoid.
Dapagliflozin
The metabolism of Dapagliflozin can be decreased when combined with Ticagrelor.
Dapsone
The metabolism of Dapsone can be decreased when combined with Ticagrelor.
Darunavir
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Darunavir resulting in a loss in efficacy.
Dasatinib
The serum concentration of Ticagrelor can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Ticagrelor can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Ticagrelor can be decreased when it is combined with Deferasirox.
Defibrotide
Defibrotide may increase the anticoagulant activities of Ticagrelor.
Delavirdine
The metabolism of Ticagrelor can be decreased when combined with Delavirdine.
Deoxycholate
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Deoxycholic Acid.
Deoxycholic Acid
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Deoxycholic Acid.
Desirudin
Ticagrelor may increase the anticoagulant activities of Desirudin.
Dexamethasone
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Dexamethasone resulting in a loss in efficacy.
Dextran
Ticagrelor may increase the anticoagulant activities of Dextran.
Dextromethorphan
The metabolism of Dextromethorphan can be decreased when combined with Ticagrelor.
Diazepam
The metabolism of Diazepam can be decreased when combined with Ticagrelor.
Diclofenac
The metabolism of Diclofenac can be decreased when combined with Ticagrelor.
Dicumarol
The metabolism of Dicoumarol can be decreased when combined with Ticagrelor.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Ticagrelor.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Ticagrelor.
Dihydroergocornine
The risk or severity of adverse effects can be increased when Dihydroergocornine is combined with Ticagrelor.
Dihydroergocristine
The risk or severity of adverse effects can be increased when Dihydroergocristine is combined with Ticagrelor.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Ticagrelor.
Diltiazem
The metabolism of Ticagrelor can be decreased when combined with Diltiazem.
Diphenhydramine
The metabolism of Diphenhydramine can be decreased when combined with Ticagrelor.
Dipyridamole
Dipyridamole may increase the anticoagulant activities of Ticagrelor.
Doconexent
The metabolism of Doconexent can be decreased when combined with Ticagrelor.
Dolasetron
The metabolism of Dolasetron can be decreased when combined with Ticagrelor.
Donepezil
The metabolism of Donepezil can be decreased when combined with Ticagrelor.
Dopamine
The metabolism of Dopamine can be decreased when combined with Ticagrelor.
Dorzolamide
The metabolism of Dorzolamide can be decreased when combined with Ticagrelor.
Doxepin
The metabolism of Doxepin can be decreased when combined with Ticagrelor.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Ticagrelor.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Ticagrelor.
Doxycycline
The metabolism of Ticagrelor can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Ticagrelor can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Ticagrelor can be decreased when combined with Dronedarone.
Drotrecogin Alfa
Ticagrelor may increase the anticoagulant activities of Drotrecogin alfa.
Edetic Acid
Ticagrelor may increase the anticoagulant activities of Edetic Acid.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Ticagrelor.
Eletriptan
The metabolism of Eletriptan can be decreased when combined with Ticagrelor.
Enasidenib
The metabolism of Enasidenib can be decreased when combined with Ticagrelor.
Enoxaparin
Ticagrelor may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Ticagrelor may increase the anticoagulant activities of Enoxaparin.
Enzalutamide
The serum concentration of Ticagrelor can be decreased when it is combined with Enzalutamide.
Epinastine
Epinastine may increase the anticoagulant activities of Ticagrelor.
Epoprostenol
The metabolism of Epoprostenol can be decreased when combined with Ticagrelor.
Eptifibatide
Eptifibatide may increase the anticoagulant activities of Ticagrelor.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Ticagrelor.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Ticagrelor.
Erythromycin
The metabolism of Ticagrelor can be decreased when combined with Erythromycin.
Estradiol
The metabolism of Estradiol can be decreased when combined with Ticagrelor.
Estradiol 3-Benzoate
The metabolism of Estradiol benzoate can be decreased when combined with Ticagrelor.
Estradiol acetate
The metabolism of Estradiol acetate can be decreased when combined with Ticagrelor.
Estradiol Cypionate
The metabolism of Estradiol cypionate can be decreased when combined with Ticagrelor.
Estradiol Valerate
The metabolism of Estradiol valerate can be decreased when combined with Ticagrelor.
Estrone
The metabolism of Estrone can be decreased when combined with Ticagrelor.
Eszopiclone
The metabolism of Eszopiclone can be decreased when combined with Ticagrelor.
Ethylenediaminetetraacetate
Ticagrelor may increase the anticoagulant activities of Edetic Acid.
Etodolac
The metabolism of Etodolac can be decreased when combined with Ticagrelor.
Etoricoxib
The metabolism of Etoricoxib can be decreased when combined with Ticagrelor.
Etravirine
The metabolism of Etravirine can be decreased when combined with Ticagrelor.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Ticagrelor.
Ferulic Acid
Ticagrelor may increase the anticoagulant activities of Ferulic acid.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Ticagrelor.
Fibrinolysis Inhibitor
The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Aprotinin.
Fluconazole
The metabolism of Ticagrelor can be decreased when combined with Fluconazole.
Fluindione
Ticagrelor may increase the anticoagulant activities of Fluindione.
Flunarizine
The metabolism of Flunarizine can be decreased when combined with Ticagrelor.
Flunitrazepam
The metabolism of Flunitrazepam can be decreased when combined with Ticagrelor.
Fluoxetine
The metabolism of Fluoxetine can be decreased when combined with Ticagrelor.
Flurbiprofen
The metabolism of Flurbiprofen can be decreased when combined with Ticagrelor.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Ticagrelor.
Fluvoxamine
The metabolism of Ticagrelor can be decreased when combined with Fluvoxamine.
Fondaparinux sodium
Ticagrelor may increase the anticoagulant activities of Fondaparinux sodium.
Formoterol
The metabolism of Formoterol can be decreased when combined with Ticagrelor.
Fosamprenavir
The metabolism of Ticagrelor can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Ticagrelor can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The serum concentration of Ticagrelor can be decreased when it is combined with Fosphenytoin.
Fusidate
The serum concentration of Ticagrelor can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Ticagrelor can be increased when it is combined with Fusidic Acid.
Gliclazide
The metabolism of Gliclazide can be decreased when combined with Ticagrelor.
Glimepiride
The metabolism of Glimepiride can be decreased when combined with Ticagrelor.
Glipizide
The metabolism of Glipizide can be decreased when combined with Ticagrelor.
Glucosamine
Glucosamine may increase the antiplatelet activities of Ticagrelor.
Glyburide
The metabolism of Glyburide can be decreased when combined with Ticagrelor.
Guanfacine
The metabolism of Guanfacine can be decreased when combined with Ticagrelor.
Haloperidol
The metabolism of Haloperidol can be decreased when combined with Ticagrelor.
Halothane
The metabolism of Halothane can be decreased when combined with Ticagrelor.
Heparin
Ticagrelor may increase the anticoagulant activities of Heparin.
Hexobarbital
The metabolism of Hexobarbital can be decreased when combined with Ticagrelor.
Histamine
The metabolism of Histamine can be decreased when combined with Ticagrelor.
Hydromorphone
The metabolism of Hydromorphone can be decreased when combined with Ticagrelor.
Hydroxytyrosol
Hydroxytyrosol may increase the anticoagulant activities of Ticagrelor.
Hypoxis hemerocallidea root extract
The serum concentration of Ticagrelor can be decreased when it is combined with St. John's Wort.
Ibritumomab Tiuxetan
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Ibritumomab tiuxetan.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Ticagrelor.
Ibuprofen
The metabolism of Ibuprofen can be decreased when combined with Ticagrelor.
Icosapent Ethyl
Icosapent ethyl may increase the anticoagulant activities of Ticagrelor.
Idarubicin
The metabolism of Idarubicin can be decreased when combined with Ticagrelor.
Idelalisib
The serum concentration of Ticagrelor can be increased when it is combined with Idelalisib.
Ifenprodil
Ifenprodil may increase the anticoagulant activities of Ticagrelor.
Ifosfamide
The metabolism of Ifosfamide can be decreased when combined with Ticagrelor.
Iloprost
Iloprost may increase the anticoagulant activities of Ticagrelor.
Imatinib
The metabolism of Ticagrelor can be decreased when combined with Imatinib.
Indinavir
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Indinavir resulting in a loss in efficacy.
INDINAVIR ANHYDROUS
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Indinavir resulting in a loss in efficacy.
Indobufen
Indobufen may increase the anticoagulant activities of Ticagrelor.
Indomethacin
The metabolism of Indomethacin can be decreased when combined with Ticagrelor.
Irbesartan
The metabolism of Irbesartan can be decreased when combined with Ticagrelor.
Isavuconazole
The serum concentration of Ticagrelor can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Ticagrelor can be decreased when combined with Isavuconazonium.
Isradipine
The metabolism of Ticagrelor can be decreased when combined with Isradipine.
Itraconazole
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Itraconazole resulting in a loss in efficacy.
Ivacaftor
The serum concentration of Ticagrelor can be increased when it is combined with Ivacaftor.
Ixazomib
The metabolism of Ixazomib can be decreased when combined with Ticagrelor.
Ketamine
The metabolism of Ketamine can be decreased when combined with Ticagrelor.
Ketanserin
Ketanserin may increase the anticoagulant activities of Ticagrelor.
Ketoconazole
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Ketoconazole resulting in a loss in efficacy.
Ketoprofen
The metabolism of Ketoprofen can be decreased when combined with Ticagrelor.
Lansoprazole
The metabolism of Lansoprazole can be decreased when combined with Ticagrelor.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Ticagrelor.
Leflunomide
The metabolism of Leflunomide can be decreased when combined with Ticagrelor.
Lepirudin
Ticagrelor may increase the anticoagulant activities of Lepirudin.
Lesinurad
The metabolism of Lesinurad can be decreased when combined with Ticagrelor.
Lidocaine
The metabolism of Lidocaine can be decreased when combined with Ticagrelor.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Ticagrelor.
Lopinavir
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Lopinavir resulting in a loss in efficacy.
Loratadine
The metabolism of Loratadine can be decreased when combined with Ticagrelor.
Lornoxicam
The metabolism of Lornoxicam can be decreased when combined with Ticagrelor.
Losartan
The metabolism of Losartan can be decreased when combined with Ticagrelor.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Ticagrelor.
Luliconazole
The serum concentration of Ticagrelor can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Ticagrelor can be decreased when it is combined with Lumacaftor.
Mefenamic Acid
The metabolism of Mefenamic acid can be decreased when combined with Ticagrelor.
Melatonin
The metabolism of Melatonin can be decreased when combined with Ticagrelor.
Meloxicam
The metabolism of Meloxicam can be decreased when combined with Ticagrelor.
Mephenytoin
The metabolism of Mephenytoin can be decreased when combined with Ticagrelor.
Mesalamine
The risk or severity of adverse effects can be increased when Mesalazine is combined with Ticagrelor.
Mestranol
The metabolism of Mestranol can be decreased when combined with Ticagrelor.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Ticagrelor.
Methadone
The metabolism of Methadone can be decreased when combined with Ticagrelor.
Methoxyflurane
The metabolism of Methoxyflurane can be decreased when combined with Ticagrelor.
Methyl Salicylate
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Methyl salicylate.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Ticagrelor.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Ticagrelor.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Ticagrelor.
Metronidazole
The metabolism of Metronidazole can be decreased when combined with Ticagrelor.
Mifepristone
The serum concentration of Ticagrelor can be increased when it is combined with Mifepristone.
Milrinone
Milrinone may increase the anticoagulant activities of Ticagrelor.
Mirtazapine
The metabolism of Mirtazapine can be decreased when combined with Ticagrelor.
Mitotane
The serum concentration of Ticagrelor can be decreased when it is combined with Mitotane.
Moclobemide
The metabolism of Moclobemide can be decreased when combined with Ticagrelor.
Montelukast
The metabolism of Montelukast can be decreased when combined with Ticagrelor.
Nadroparin
Ticagrelor may increase the anticoagulant activities of Nadroparin.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Ticagrelor.
Naproxen
The metabolism of Naproxen can be decreased when combined with Ticagrelor.
Nateglinide
The metabolism of Nateglinide can be decreased when combined with Ticagrelor.
Nefazodone
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Nefazodone resulting in a loss in efficacy.
Nelfinavir
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Nelfinavir resulting in a loss in efficacy.
Netupitant
The serum concentration of Ticagrelor can be increased when it is combined with Netupitant.
Nevirapine
The serum concentration of Ticagrelor can be decreased when it is combined with Nevirapine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Ticagrelor.
Niclosamide
The metabolism of Niclosamide can be decreased when combined with Ticagrelor.
Nicotine
The metabolism of Nicotine can be decreased when combined with Ticagrelor.
Nicotine Polacrilex
The metabolism of Nicotine can be decreased when combined with Ticagrelor.
Nilotinib
The metabolism of Ticagrelor can be decreased when combined with Nilotinib.
Nimesulide
Nimesulide may increase the anticoagulant activities of Ticagrelor.
Nintedanib
The serum concentration of Nintedanib can be increased when it is combined with Ticagrelor.
Nortriptyline
The metabolism of Nortriptyline can be decreased when combined with Ticagrelor.
Obinutuzumab
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Obinutuzumab.
Olaparib
The metabolism of Ticagrelor can be decreased when combined with Olaparib.
Olodaterol
The metabolism of Olodaterol can be decreased when combined with Ticagrelor.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Ticagrelor.
Omega-3 Fatty Acids
Omega-3 fatty acids may increase the antiplatelet activities of Ticagrelor.
Omeprazole
The metabolism of Omeprazole can be decreased when combined with Ticagrelor.
Ondansetron
The metabolism of Ondansetron can be decreased when combined with Ticagrelor.
Osimertinib
The serum concentration of Ticagrelor can be increased when it is combined with Osimertinib.
Ospemifene
The metabolism of Ospemifene can be decreased when combined with Ticagrelor.
Oxaprozin
The metabolism of Oxaprozin can be decreased when combined with Ticagrelor.
Paclitaxel
The metabolism of Paclitaxel can be decreased when combined with Ticagrelor.
Palbociclib
The serum concentration of Ticagrelor can be increased when it is combined with Palbociclib.
Paramethadione
The metabolism of Paramethadione can be decreased when combined with Ticagrelor.
Parecoxib
The metabolism of Parecoxib can be decreased when combined with Ticagrelor.
Parnaparin
Ticagrelor may increase the anticoagulant activities of Parnaparin.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Ticagrelor.
Pentaerythritol Tetranitrate
Ticagrelor may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentobarbital
The serum concentration of Ticagrelor can be decreased when it is combined with Pentobarbital.
Pentosan Polysulfate
The risk or severity of adverse effects can be increased when Pentosan Polysulfate is combined with Ticagrelor.
Pentoxifylline
Pentoxifylline may increase the antiplatelet activities of Ticagrelor.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Ticagrelor.
Perphenazine
The metabolism of Perphenazine can be decreased when combined with Ticagrelor.
Phenacetin
The metabolism of Phenacetin can be decreased when combined with Ticagrelor.
Phenindione
Ticagrelor may increase the anticoagulant activities of Phenindione.
Phenobarbital
The serum concentration of Ticagrelor can be decreased when it is combined with Phenobarbital.
Phenprocoumon
The metabolism of Phenprocoumon can be decreased when combined with Ticagrelor.
Phenylbutazone
The metabolism of Phenylbutazone can be decreased when combined with Ticagrelor.
Phenytoin
The serum concentration of Ticagrelor can be decreased when it is combined with Phenytoin.
Phospholipids
Omega-3 fatty acids may increase the antiplatelet activities of Ticagrelor.
Pioglitazone
The metabolism of Pioglitazone can be decreased when combined with Ticagrelor.
Piroxicam
The metabolism of Piroxicam can be decreased when combined with Ticagrelor.
Piroxicam-Beta-Cyclodextrin
The metabolism of Piroxicam can be decreased when combined with Ticagrelor.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Ticagrelor.
Plasmin
Ticagrelor may increase the anticoagulant activities of Fibrinolysin.
Posaconazole
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Posaconazole resulting in a loss in efficacy.
Potassium Citrate
Ticagrelor may increase the anticoagulant activities of Potassium Citrate.
Prasugrel
The metabolism of Prasugrel can be decreased when combined with Ticagrelor.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Ticagrelor.
Primidone
The serum concentration of Ticagrelor can be decreased when it is combined with Primidone.
Progesterone
The metabolism of Progesterone can be decreased when combined with Ticagrelor.
Proguanil
The metabolism of Proguanil can be decreased when combined with Ticagrelor.
Promazine
The metabolism of Promazine can be decreased when combined with Ticagrelor.
Propofol
The metabolism of Propofol can be decreased when combined with Ticagrelor.
protein C, human
Ticagrelor may increase the anticoagulant activities of Protein C.
protein S, human
Ticagrelor may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Ticagrelor may increase the anticoagulant activities of Protocatechualdehyde.
Quazepam
The metabolism of Quazepam can be decreased when combined with Ticagrelor.
Quinidine
The metabolism of Quinidine can be decreased when combined with Ticagrelor.
Quinine
The metabolism of Quinine can be decreased when combined with Ticagrelor.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Ticagrelor.
Resveratrol
Resveratrol may increase the anticoagulant activities of Ticagrelor.
Reteplase
Ticagrelor may increase the anticoagulant activities of Reteplase.
Reviparin
Ticagrelor may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Ticagrelor may increase the anticoagulant activities of Reviparin.
Ribociclib
The serum concentration of Ticagrelor can be increased when it is combined with Ribociclib.
Rifabutin
The serum concentration of Ticagrelor can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Ticagrelor can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Ticagrelor can be decreased when it is combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Ticagrelor.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Ticagrelor.
Rivaroxaban
Ticagrelor may increase the anticoagulant activities of Rivaroxaban.
Rofecoxib
The metabolism of Rofecoxib can be decreased when combined with Ticagrelor.
Rosiglitazone
The metabolism of Rosiglitazone can be decreased when combined with Ticagrelor.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Ticagrelor.
Rucaparib
The metabolism of Ticagrelor can be decreased when combined with Rucaparib.
Salicylic Acid
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Salicylic acid.
Saquinavir
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Saquinavir resulting in a loss in efficacy.
Saquinavir Mesylate
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Saquinavir resulting in a loss in efficacy.
Sarilumab
The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Sarilumab.
Selegiline
The metabolism of Selegiline can be decreased when combined with Ticagrelor.
Selexipag
Ticagrelor may increase the anticoagulant activities of Selexipag.
Sertraline
The metabolism of Sertraline can be decreased when combined with Ticagrelor.
Sevoflurane
Sevoflurane may increase the anticoagulant activities of Ticagrelor.
Sildenafil
The metabolism of Ticagrelor can be decreased when combined with Sildenafil.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Ticagrelor.
Siltuximab
The serum concentration of Ticagrelor can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Ticagrelor can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Ticagrelor.
Sodium Citrate
Ticagrelor may increase the anticoagulant activities of Sodium Citrate.
ST. JOHN'S WORT EXTRACT
The serum concentration of Ticagrelor can be decreased when it is combined with St. John's Wort.
Streptokinase
Ticagrelor may increase the anticoagulant activities of Streptokinase.
Sulfadiazine
The metabolism of Sulfadiazine can be decreased when combined with Ticagrelor.
Sulfamethoxazole
The metabolism of Sulfamethoxazole can be decreased when combined with Ticagrelor.
Sulfamoxole
The metabolism of Sulfamoxole can be decreased when combined with Ticagrelor.
Sulfinpyrazone
The metabolism of Sulfinpyrazone can be decreased when combined with Ticagrelor.
Sulfisoxazole
The metabolism of Ticagrelor can be decreased when combined with Sulfisoxazole.
Suprofen
The metabolism of Suprofen can be decreased when combined with Ticagrelor.
Tamoxifen
The metabolism of Tamoxifen can be decreased when combined with Ticagrelor.
Tapentadol
The metabolism of Tapentadol can be decreased when combined with Ticagrelor.
Telaprevir
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Telaprevir resulting in a loss in efficacy.
Telithromycin
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Telithromycin resulting in a loss in efficacy.
Temazepam
The metabolism of Temazepam can be decreased when combined with Ticagrelor.
Tenecteplase
Ticagrelor may increase the anticoagulant activities of Tenecteplase.
Tenoxicam
The metabolism of Tenoxicam can be decreased when combined with Ticagrelor.
Terbinafine
The metabolism of Terbinafine can be decreased when combined with Ticagrelor.
Terfenadine
The metabolism of Terfenadine can be decreased when combined with Ticagrelor.
Testosterone
The metabolism of Testosterone can be decreased when combined with Ticagrelor.
Testosterone Cypionate
The metabolism of Testosterone cypionate can be decreased when combined with Ticagrelor.
Testosterone Enanthate
The metabolism of Testosterone enanthate can be decreased when combined with Ticagrelor.
Testosterone Undecanoate
The metabolism of Testosterone undecanoate can be decreased when combined with Ticagrelor.
Tetrahydrocannabinol
The serum concentration of Dronabinol can be increased when it is combined with Ticagrelor.
Thalidomide
The metabolism of Thalidomide can be decreased when combined with Ticagrelor.
Theophylline
The metabolism of Theophylline can be decreased when combined with Ticagrelor.
Theophylline anhydrous
The metabolism of Theophylline can be decreased when combined with Ticagrelor.
Thiamylal
The metabolism of Thiamylal can be decreased when combined with Ticagrelor.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Ticagrelor.
Ticlopidine
The metabolism of Ticagrelor can be decreased when combined with Ticlopidine.
Tinzaparin
Ticagrelor may increase the anticoagulant activities of Tinzaparin.
Tinzaparin sodium
Ticagrelor may increase the anticoagulant activities of Tinzaparin.
Tipranavir
Tipranavir may increase the antiplatelet activities of Ticagrelor.
Tirofiban
Tirofiban may increase the anticoagulant activities of Ticagrelor.
Tocilizumab
The serum concentration of Ticagrelor can be decreased when it is combined with Tocilizumab.
Tolbutamide
The metabolism of Tolbutamide can be decreased when combined with Ticagrelor.
Tolterodine
The metabolism of Tolterodine can be decreased when combined with Ticagrelor.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Ticagrelor.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Ticagrelor.
Torsemide
The metabolism of Torasemide can be decreased when combined with Ticagrelor.
Tositumomab
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Tositumomab.
Trabectedin
The metabolism of Trabectedin can be decreased when combined with Ticagrelor.
Tranilast
Tranilast may increase the anticoagulant activities of Ticagrelor.
Trapidil
Trapidil may increase the anticoagulant activities of Ticagrelor.
Treprostinil
The metabolism of Treprostinil can be decreased when combined with Ticagrelor.
Tretinoin
The metabolism of Tretinoin can be decreased when combined with Ticagrelor.
Triflusal
Triflusal may increase the anticoagulant activities of Ticagrelor.
Trimethadione
The metabolism of Trimethadione can be decreased when combined with Ticagrelor.
Trimethoprim
The metabolism of Trimethoprim can be decreased when combined with Ticagrelor.
Trimipramine
The metabolism of Trimipramine can be decreased when combined with Ticagrelor.
Trisodium Citrate Anhydrous
Ticagrelor may increase the anticoagulant activities of Sodium Citrate.
Troglitazone
The metabolism of Troglitazone can be decreased when combined with Ticagrelor.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Trolamine salicylate.
Troxerutin
Ticagrelor may increase the anticoagulant activities of Troxerutin.
Urokinase
Ticagrelor may increase the anticoagulant activities of Urokinase.
Valdecoxib
The metabolism of Valdecoxib can be decreased when combined with Ticagrelor.
Valproate
The metabolism of Valproic Acid can be decreased when combined with Ticagrelor.
Valproic Acid
The metabolism of Valproic Acid can be decreased when combined with Ticagrelor.
Valsartan
The metabolism of Valsartan can be decreased when combined with Ticagrelor.
Vemurafenib
The serum concentration of Ticagrelor can be increased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Ticagrelor can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Ticagrelor can be decreased when combined with Verapamil.
Vincristine
The excretion of Vincristine can be decreased when combined with Ticagrelor.
Vismodegib
The metabolism of Vismodegib can be decreased when combined with Ticagrelor.
Vitamin E
Vitamin E may increase the antiplatelet activities of Ticagrelor.
Vorapaxar
Vorapaxar may increase the anticoagulant activities of Ticagrelor.
Voriconazole
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Voriconazole resulting in a loss in efficacy.
Vortioxetine
The metabolism of Vortioxetine can be decreased when combined with Ticagrelor.
Warfarin
The metabolism of Warfarin can be decreased when combined with Ticagrelor.
Zafirlukast
The metabolism of Zafirlukast can be decreased when combined with Ticagrelor.
Zalcitabine
The metabolism of Zalcitabine can be decreased when combined with Ticagrelor.
Zidovudine
The metabolism of Zidovudine can be decreased when combined with Ticagrelor.
Zileuton
The metabolism of Zileuton can be decreased when combined with Ticagrelor.
Ziprasidone
The metabolism of Ticagrelor can be decreased when combined with Ziprasidone.
Zolpidem
The metabolism of Zolpidem can be decreased when combined with Ticagrelor.
Zopiclone
The metabolism of Zopiclone can be decreased when combined with Ticagrelor.
